JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

JMP Securities analyst Mitchell Germain maintained a Hold rating on The RMR Group (RMR – Research Report) today. The company’s shares closed ...

Shares of Aviat Networks Inc. (AVNW) surged over 19% during pre-market trade on Wednesday as analysts at JMP Securities ...

Roku Inc. (NASDAQ:ROKU) posted excellent fiscal third-quarter 2024 results, exceeding $1 billion in total net sales for the ...

JMP Securities maintained its Market Perform rating on Apollo Global Management (NYSE:APO) shares without setting a new price ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

Full-year 2024 core EPS reached $3.18, more than double the 2023 results, with a core return on equity of 8.8%. She highlighted that the company has fully restored Property & Casualty profitability, ...

AI is evolving rapidly with recent breakthroughs making it more accessible and efficient than ever. Smaller, cost-effective ...

We recently compiled a list of the 12 AI News Investors Probably Missed. In this article, we are going to take a look at ...

The web services and cybersecurity specialist's share price ended the day's trading up 10.7% amid the backdrop of a 0.8% gain ...

Even with its well-documented benefits, DoE is often underutilised, especially for solving specialised or constrained ...